Melanoma trials in Switzerland

In Switzerland 14 Also abroad 578

14 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
Where
Basel, Bellinzona, Bern, Fribourg, Geneva, Lausanne, Münsterlingen, Sankt Gallen, Zurich
Age
18 years and over
People
108
Run by
Swiss Cancer Institute
See details and how to joinNCT07574047
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Chur, Zurich
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 3Taking people
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Where
Lausanne
Age
18 years to 70 years
People
670 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00
No phaseNot yet taking people in Switzerland
A Comparative Usability Study of Two Total Body Skin Imaging Systems
Where
Basel
Age
18 years and over
People
60
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07740642
Phase 1Taking people
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Where
Lausanne
Age
18 years and over
People
9
Run by
Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT06889766
Phase 3Taking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Basel, Zurich
Age
18 years and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
Phase 3Taking people
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Where
Bern, Winterthur, Zurich
Age
18 years and over
People
180 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT05522660
Phase 2Not yet taking people in Switzerland
Screening for Brain Metastases
Where
Zurich
Age
18 years and over
People
180
Run by
University of Zurich
See details and how to joinNCT07492121
Phase 3Taking people
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Where
Sankt Gallen, Zurich
Age
18 years and over
People
540 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00
Phase 3Taking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Zurich
Age
18 years and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
Phase 3Taking people
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Where
Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
Age
18 years and over
People
186 worldwide
Run by
Philogen S.p.A.
See details and how to joinNCT03567889 · EU 2023-507119-36-00
No phaseTaking people
Skin Cancer and Hyperthermia and Radiotherapy
Where
Aarau, Bern, Lucerne, Winterthur
Age
65 years and over
People
100
Run by
Kantonsspital Winterthur KSW
See details and how to joinNCT06384053
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Bern, Zurich
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
No phaseTaking people
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Where
Aarau, Bellinzona, Bern, Chur, Lausanne, Lucerne, Winterthur, Zurich
Age
18 years and over
People
750 worldwide
Run by
Pierre Fabre Pharma GmbH
See details and how to joinNCT04045691